Breaking: Pfizer says covid vaccine 90% effective, markets jump, dollar falls

Yohay Elam FXStreet

Pharmaceutical giant Pfizer has said that its COVID-19 vaccine study has shown that it prevents 90% of infections and that no serious safety concerns have been identified as of the first interim analysis. The company has been developing a vaccine with Germany's BioNTech. No fewer than 43,500 have been participating in the Phase 3 trial.

Developers say it is a "great day for science and humanity" and will apply for emergency approval to use the vaccine by the end of November. Pfizer believes it can supply it 50 million doses by the end of 2020 and 1.3bn by end of 2021.

Equities are jumping with S&P futures up 3%. The safe-haven dollar is falling. with EUR/USD nearing 1.19. GBP/USD has advanced toward 1.21 and USD/JPY is above 104, amid a diminishing need for the safe-haven yen. Gold is falling as the need for stimulus is falling.

Commodities are also on the rise, here is how the move looks on oil prices:

Author

Yohay Elam

FXStreet

Yohay is in Forex since 2008 when he founded Forex Crunch, a blog crafted in his free time that turned into a fully-fledged currency website later sold to Finixio.

EUR/USD struggles aroound 1.1800 as USD stabilizes

EUR/USD stays defensive around 1.1800 in the European session on Thursday. The US Dollar stabilizes, following the recent decline led by tariff uncertainty, capping the pair's upside. All eyes now remain on the US-Iran nuclear talks after ECB President Lagarde's testimony fails to impress Euro bulls.

GBP/USD drops toward 1.3500 as USD finds fresh demand

GBP/USD falls back toward 1.3500 in the European session on Thursday, snapping its recovery momentum. The pair loses traction as the US Dollar finds fresh demand, as markets turn cautious ahead of the US-Iran nuclear talks. The US trade policy uncertainty also remains a drag on risk sentiment.

Gold clings to gains amid sustained safe-haven flows ahead of US-Iran talks

Gold sticks to its modest intraday gains through the first half of the European session on Thursday, with bulls still awaiting a sustained move and acceptance above the $5,200 mark before placing fresh bets.

Stellar: Relief bounce fades as bearish undertone persists

Stellar is trading around $0.16 at the time of writing on Thursday after rebounding more than 8% in the previous day. Derivatives data paints a negative picture as XLM’s short bets hit a monthly high while Open Interest continues to decline.

The one thing everyone is on the lookout for is US action of some sort against Iran

The FX market is minestrone soup these days. It is befuddled by conflicting data, rumors and small stories exaggerated out of proportion, and Trump-generated uncertainty.

Solana strikes key resistance with double-digit gains

Solana trades at $88 at press time on Thursday, after an 11% upswing the previous day within a broader consolidation range of roughly three weeks. Institutional demand for Solana heightens as US spot SOL Exchange Traded Funds record $30 million of inflow on Wednesday.